Commodore Capital LP Enanta Pharmaceuticals Inc Transaction History

Commodore Capital LP

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$38.82 - $54.59 $242,275 - $340,696
-6,241 Reduced 2.79%
217,253 $8.79 Million
Q4 2022

Feb 14, 2023
BUY
$40.77 - $53.73 $4.89 Million - $6.45 Million
120,000 Added 115.95%
223,494 $10.4 Million
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $5 Million - $7.38 Million
103,494 New
103,494 $5.37 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email